NasdaqGS:TEMLife Sciences
Tempus AI (TEM) Valuation Check After New Keck Medicine Partnership Spurs Fresh Growth Expectations
Tempus AI (TEM) just announced a broad collaboration with Keck Medicine of USC that will plug its molecular diagnostics and AI tools into a network handling over 1.5 million annual patient visits across Southern California.
See our latest analysis for Tempus AI.
The Keck collaboration and recent product launches come after a mixed stretch for the stock, with an 11.46% 30 day share price return, a 16.42% year to date share price decline, and a 1.47% 1 year total shareholder return fall. This...